The association's Strategic Research Committee (SRC) reaffirms its interest in any research project likely to improve the fight against cystic fibrosis, whether in basic or clinical research, or in the human and social sciences. The CSR draws the attention of the scientific community to several current themes of interest:
- New therapeutic approaches for patients (rare mutations) not targeted by CFTR modulators
- Transplants and specific issues for transplant patients
- Emerging issues and co-morbidities
- New therapeutic approaches for all patients
- New symptomatic treatments for respiratory, digestive and inflammatory diseases
- Prenatal diagnosis
In addition, the CSR encourages researchers to propose projects using data from the French Cystic Fibrosis Registry.
The deadline for submission of letters of intent in Clinical Research and in SHS is: Sunday 13 November 2022 (midnight).
Completed applications (any research area) must be submitted no later than: Monday, March 6, 2023 (midnight).
To learn more about PA2023: https: //www.vaincrelamuco.org/guerir-demain/chercheurs/appel-projets-de-recherche-sur-la-mucoviscidose-2023-ap2023